Marina Biotech major shareholder Cashman Llp Pryor Sells 108,041 Shares (MRNA)
Marina Biotech (NASDAQ:MRNA) major shareholder Cashman Llp Pryor sold 108,041 shares of Marina Biotech stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $0.99, for a total transaction of $106,960.59. Following the completion of the sale, the insider now directly owns 1,591,959 shares in the company, valued at approximately $1,576,039. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Shares of Marina Biotech (NASDAQ:MRNA) traded up 9.47% on Monday, hitting $1.04. The stock had a trading volume of 283,682 shares. Marina Biotech has a 52-week low of $0.18 and a 52-week high of $1.10. The stock has a 50-day moving average of $0.66 and a 200-day moving average of $0.35. The company’s market cap is $17.6 million.
Marina Biotech Inc, formerly MDRNA, Inc, is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference (NASDAQ:MRNA).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.